Skip to main content

Peer Review reports

From: Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review

Original Submission
2 Dec 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
20 Jan 2022 Reviewed Reviewer Report
29 Jan 2022 Reviewed Reviewer Report - Juan C Martínez-castrillo
17 Feb 2022 Author responded Author comments - Matteo Vismara
Resubmission - Version 4
17 Feb 2022 Submitted Manuscript version 4
29 Mar 2022 Author responded Author comments - Matteo Vismara
Resubmission - Version 5
29 Mar 2022 Submitted Manuscript version 5
4 Apr 2022 Reviewed Reviewer Report - Juan C Martínez-castrillo
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
7 Apr 2022 Editorially accepted
5 May 2022 Article published 10.1186/s12883-022-02668-4

You can find further information about peer review here.

Back to article page